Skip to main content

Cardiovascular Disease: Impact of Biomarkers, Proteomics, and Genomics.

Publication ,  Journal Article
Apple, FS; Cullen, L; Felker, GM; Ginsburg, G; Morrow, D
Published in: Clin Chem
January 2017

Duke Scholars

Published In

Clin Chem

DOI

EISSN

1530-8561

Publication Date

January 2017

Volume

63

Issue

1

Start / End Page

1 / 4

Location

England

Related Subject Headings

  • Proteomics
  • Male
  • Humans
  • Genomics
  • General Clinical Medicine
  • Female
  • Cardiovascular Diseases
  • Biomarkers
  • 3205 Medical biochemistry and metabolomics
  • 3202 Clinical sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Apple, F. S., Cullen, L., Felker, G. M., Ginsburg, G., & Morrow, D. (2017). Cardiovascular Disease: Impact of Biomarkers, Proteomics, and Genomics. Clin Chem, 63(1), 1–4. https://doi.org/10.1373/clinchem.2016.263350
Apple, Fred S., Louise Cullen, G Michael Felker, Geoffrey Ginsburg, and David Morrow. “Cardiovascular Disease: Impact of Biomarkers, Proteomics, and Genomics.Clin Chem 63, no. 1 (January 2017): 1–4. https://doi.org/10.1373/clinchem.2016.263350.
Apple FS, Cullen L, Felker GM, Ginsburg G, Morrow D. Cardiovascular Disease: Impact of Biomarkers, Proteomics, and Genomics. Clin Chem. 2017 Jan;63(1):1–4.
Apple, Fred S., et al. “Cardiovascular Disease: Impact of Biomarkers, Proteomics, and Genomics.Clin Chem, vol. 63, no. 1, Jan. 2017, pp. 1–4. Pubmed, doi:10.1373/clinchem.2016.263350.
Apple FS, Cullen L, Felker GM, Ginsburg G, Morrow D. Cardiovascular Disease: Impact of Biomarkers, Proteomics, and Genomics. Clin Chem. 2017 Jan;63(1):1–4.

Published In

Clin Chem

DOI

EISSN

1530-8561

Publication Date

January 2017

Volume

63

Issue

1

Start / End Page

1 / 4

Location

England

Related Subject Headings

  • Proteomics
  • Male
  • Humans
  • Genomics
  • General Clinical Medicine
  • Female
  • Cardiovascular Diseases
  • Biomarkers
  • 3205 Medical biochemistry and metabolomics
  • 3202 Clinical sciences